ArticleOncotarget2016

Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma.

Askar Obulkasim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.